FDA Alerts

The US Food and Drug Administration has granted approval to the first treatment in a new drug class for a nerve condition that affects about 50,000 people worldwide.

Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...

Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...

The FDA has approved an oral gonadotropin-releasing hormone antagonist for the treatment of moderate to severe endometriosis pain.

The FDA has approved an 8-aminoquinoline derivative for the treatment of patients with Plasmodium vivax malaria.

With concerns of bioterrorism in mind, the US Food and Drug Administration has approved the first drug with an indication for the treatment of smallpox.

The FDA has issued label changes for a class of antibiotics used for the treatment of certain serious bacterial infections.

The US Food and Drug Administration has approved a new anticholinergic cloth for the topical treatment of primary axillary hyperhidrosis.

In 2010, the FDA mandated that 4 companies marketing long-acting β2 agonists perform trials comparing the safety of combination therapy with LABA plus an inhaled glucocorticoid vs an inhaled glucocorticoid...

Based on the results of 3 placebo-controlled studies, the FDA has approved a new drug derived from a component of the cannabis sativa plant for the treatment of 2 rare forms of epilepsy.